UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029280
Receipt number R000033467
Scientific Title Multicenter prospective study on effectiveness of color visual field test
Date of disclosure of the study information 2017/09/25
Last modified on 2022/03/29 16:47:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter prospective study on effectiveness of color visual field test

Acronym

Evaluation of effectiveness of color visual field test

Scientific Title

Multicenter prospective study on effectiveness of color visual field test

Scientific Title:Acronym

Evaluation of effectiveness of color visual field test

Region

Japan


Condition

Condition

Healthy patient without ophthalmologic disease, glaucoma, early diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, central serous chorioretinopathy, epiretinal membrane, and macular hole

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

There was no abnormality on visual field text for early glaucoma, but there is change on epiretinal structure. Even when the retinal disease patient with good visual acuity claims difficulty to see, abnormality may not be detected by existing test. Assuming that this may be an abnormality outside the range, visual acuity test using color as high sensitivity subjective test was developed. Goal of this study is to evaluate the effectiveness of the test.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Find the significant difference by comparing the retinal sensitivity between normal group and disease group

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patient who receive explanation and agreed to participate in this study

Key exclusion criteria

Congenital color vision defect

Target sample size

160


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Sato

Organization

Yuya Sato Eye Clinic

Division name

Yuya Sato Eye Clinic

Zip code

980-0022

Address

1-6-23 Itsutsubashi Aobaku Sendai

TEL

022-227-6752

Email

sato@chukyogroup.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Sato

Organization

Yuya Sato Eye Clinic

Division name

Yuya Sato Eye Clinic

Zip code

980-0022

Address

1-6-23 Itsutsubashi Aobaku Sendai

TEL

022-227-6752

Homepage URL


Email

sato@chukyogroup.jp


Sponsor or person

Institute

Yuya Sato Eye Clinic

Institute

Department

Personal name



Funding Source

Organization

Chukyo Medical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Chukyo Eye Clinic Vision Research Laboratory
JCHO Chukyo Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Chukyo Medical Co., Ltd. REC

Address

12-23, Sanbonmatsu-cho, Atsuta-ku, Nagoya-city, Aichi

Tel

052-884-7976

Email

irb@chukyomedical.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 09 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 09 Month 25 Day

Date of IRB

2017 Year 09 Month 22 Day

Anticipated trial start date

2017 Year 09 Month 25 Day

Last follow-up date

2022 Year 03 Month 29 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Find the significant difference by comparing the retinal sensitivity between normal group and disease group


Management information

Registered date

2017 Year 09 Month 25 Day

Last modified on

2022 Year 03 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033467


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name